PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 83 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $98,000 | -27.4% | 318,605 | +1.6% | 0.00% | – |
| Q3 2016 | $135,000 | +39.2% | 313,466 | +17.6% | 0.00% | – |
| Q2 2016 | $97,000 | +83.0% | 266,605 | +110.9% | 0.00% | – |
| Q1 2016 | $53,000 | -23.2% | 126,423 | +114.4% | 0.00% | – |
| Q4 2015 | $69,000 | +176.0% | 58,955 | +203.3% | 0.00% | – |
| Q2 2015 | $25,000 | -26.5% | 19,437 | -23.7% | 0.00% | – |
| Q1 2015 | $34,000 | +6.2% | 25,467 | +11.5% | 0.00% | – |
| Q4 2014 | $32,000 | +39.1% | 22,831 | +32.5% | 0.00% | – |
| Q3 2014 | $23,000 | -68.5% | 17,233 | -55.7% | 0.00% | – |
| Q2 2014 | $73,000 | +15.9% | 38,865 | +17.6% | 0.00% | – |
| Q1 2014 | $63,000 | +21.2% | 33,049 | -10.9% | 0.00% | – |
| Q4 2013 | $52,000 | +92.6% | 37,091 | +89.0% | 0.00% | – |
| Q3 2013 | $27,000 | -94.9% | 19,625 | -95.2% | 0.00% | – |
| Q2 2013 | $532,000 | +174.2% | 412,744 | +15.2% | 0.00% | – |
| Q2 2012 | $194,000 | +223.3% | 358,378 | +224.2% | 0.00% | – |
| Q1 2012 | $60,000 | – | 110,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 148,006 | $206,000 | 0.10% |
| First Heartland Consultants, Inc. | 86,204 | $120,000 | 0.07% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 671,900 | $934,000 | 0.02% |
| Investors Capital Advisory Services | 47,238 | $65,000 | 0.02% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $28,000 | 0.01% |
| Commonwealth Equity Services, Inc | 481,140 | $669,000 | 0.01% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 11,300 | $16,000 | 0.01% |
| First Allied Advisory Services, Inc. | 50,000 | $70,000 | 0.01% |
| Winslow, Evans & Crocker, Inc. | 13,200 | $18,000 | 0.01% |
| AMALGAMATED BANK | 16,650 | $23,000 | 0.00% |